21-day Double-blind Trial of Albendazole in Adults With Loa Loa Microfilaremia
Status:
NOT_YET_RECRUITING
Trial end date:
2027-12-31
Target enrollment:
Participant gender:
Summary
Our aim is to test the hypothesis that a 3-week course of albendazole 400 mg daily is safe and can progressively reduce Loa loa microfilarial densities in subjects with microfilaremia.
Phase:
PHASE3
Details
Lead Sponsor:
Programme National de Lutte contre l'Onchocercose, Republic of the Congo